Search
Search Results
- Publication:
- Washington, DC : United States Government Accountability Office, October 2017
- Subject(s):
- Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Outcome Assessment (Health Care)
Community-Institutional Relations
Buprenorphine -- therapeutic use
Inservice Training
Insurance Coverage
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Prescription Drug Diversion -- prevention & control
Humans
United States
United States. Department of Health and Human Services.
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022
- Subject(s):
- Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services.
- Publication:
- Washington, DC : United States Government Accountability Office, August 2020
- Subject(s):
- Buprenorphine -- therapeutic use
Government Regulation
Opiate Substitution Treatment
Opioid-Related Disorders -- therapy
Substance Withdrawal Syndrome -- therapy
United States
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, February 2019
- Subject(s):
- Buprenorphine -- therapeutic use
Drug Development
Opioid-Related Disorders -- drug therapy
Buprenorphine -- administration & dosage
Clinical Trials as Topic
Delayed-Action Preparations
Narcotic Antagonists
Opiate Substitution Treatment
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.